Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension (IRE-HT)

9 september 2026 bijgewerkt door: Kam Sang WOO, Chinese University of Hong Kong

The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension: A Substudy of Randomized Controlled Trial

Background:

Hypertension (HT) is the most common condition worldwide, predisposing to atherosclerotic disease. However, most HT patients have suboptimal BP control despite anti-HT medications. Isometric resistance exercise (IRE) (e.g. wall squat) may improve BP control, characterized by sustained muscle contraction with minimal change in muscle length and joint angle. Most randomized trials of IRE are short duration and their long-term effects on BP and atherosclerotic complications, particularly in the Chinese, remain unknown.

Study objectives:

(i) To evaluate the impact of IRE on atherogenesis surrogates (brachial flow-mediated dilation, FMD and carotid intima-media thickness IMT).

(ii) To evaluate the impact of IRE on mechanisms of atherogenesis improvement, inflammatory parameters, arterial wall stiffness and biochemical profiles.

Setting:

Randomized samples of 200 HT patients, aged >18years with systolic BP 135-160mHg while on no or stable anti-HT medications.

Design: Randomized controlled IRE trial - stratified randomization with randomization block size of 4.

  1. 100 patients for wall squat exercise of 14 mins each session (2 mins IRE x 4 sets, 2 mins rest in between), 3 sessions per week, for 1 year, plus advice on healthy diet and lifestyle.
  2. 100 control patients (usual care) with advice on diet and healthy lifestyles and simple stretching exercise programme for 1 year.

Main outcome measures:

  1. Brachial FMD and carotid IMT at baseline, 24 weeks and 1 year. (primary outcome)
  2. Carotid-femoral pulse wave velocity (cf-PWV) at baseline and 24 weeks. (secondary outcome)
  3. Important atherosclerosis risk factor parameters at baseline, 24 weeks and 1 year - including fasting serum glucose, lipid profiles, HgbA1-C, creatinine, hs-CRP, CBP, fibrinogen, and interleukin 6 (IL-6). (secondary outcome)
  4. Safety profiles (if any) including CVS event and hospitalization at 1 year.

Expected results:

A group absolute difference in FMD of 1%, and in carotid IMT of 0.06mm between IRE intervention and control groups.

Implications: IRE as suggested will be beneficial to management of HT for atherosclerosis preventions.

Studie Overzicht

Gedetailleerde beschrijving

  1. Introduction

    Hypertension (HT) is the most common condition worldwide predisposing to atherosclerotic diseases (stroke, heart attack and peripheral vascular disease), apart from other traditional risk factors [1-3]. However, most HT patients have suboptimal BP control despite anti-HT medications [4]. On this issue, aerobic and dynamic exercise are effective in BP-reduction, but HT-patients often have poor compliance with exercise, mainly because of requirement of additional time, skill training, venue and equipments [5-6]. Isometric resistance exercised (IRE) (e.g. wall squat) may improve BP control, characterized by sustained muscle contractions with minimal change in muscle length and joint angle. However, most randomized trials of IRE have short duration and their long-term effect on BP-reduction, mechanisms and atherosclerosis complications, particularly in the Chinese, remain unknown [7-11].

    Much advance in noninvasive vessel-imaging has been witnessed in past few decades. Brachial flow-mediated dilation (FMD) and carotid intima-media thickness (IMT), have been advocated as surrogate markers for the documentation of early atherosclerosis and evaluation of preventive measures (12-20). Both brachial FMD and carotid IMT can now be measured accurately with high reproducibility, and have been related to cardiovascular outcomes. In clinical context, a 0.1mm increase in carotid IMT has been associated with 41% increase in stroke and 43% increase in acute myocardial infarction over a follow-up period of 2-7 years. [17] An 8% difference in carotid IMT was approximately similar to the kind of difference seen between diabetes and non-diabetes Chinese adults [21).

  2. Aims and Hypotheses to be Tested

    Systemic hypertension has been proven accelerating atherosclerotic process. To further test this initial hypothesis, this interventional substudy aims:

    (i) To evaluate the impact of IRE on atherosclerotic surrogates (brachial FMD and carotid IMT).

    (ii) To evaluate the impact of IRE on mechanisms of BP and atherogenesis reductions, including endothelial function FMD, carotid IMT and arterial wall stiffness (cfPWV), and inflammatory parameters.

  3. Plan of Investigation The brachial FMD and carotid IMT before and after IRE intervention will be compared between the wall-squat and control intervention groups.

3.1 The impact of Isometric resistance exercise (IRE) Intervention on brachial FMD and carotid IMT.

Subjects:

200 HT adults, aged >18 years with SBP 135-160mmHg on AMBP will be recruited. Those with incapacitating osteoarthritis of knee and secondary HT will be excluded.

3.2 Methods: These HT participants will be randomized to practise IRE (100 adults) 14 mins per session, (2 mins IRE x 4sets, 2 mins rest in between), 3 sessions per week, or usual standard care & stretching (yoga) exercise (100 adults).

Week-0 ~ Health Examination, Randomization (IRE vs Yoga), Vascular Study (FMD & IMT), Blood Test, and Arterial wall stiffness (cfPWV)

Week-13 ~ Compliance (adhenence) checking

Week-24 ~ Health Examination, vascular study (FMD & IMT), blood tests, and arterial wall stiffness (cfPWV)

One Year ~ Compliance (adherence) checking, vascular study (FMD & IMT), vessel wall stiffness, and blood Tests

  • Collection of health data:

    1. Questionnaire - All adult subjects will be interviewed and required to complete a detailed questionnaire regarding their individual and family history of cardiovascular diseases, hypertension, diabetes and current use of medications. Information on socio-economic status, tobacco use and lifestyle will be collected.
    2. Health examination - Each participant will receive a health examination and their weight and height, blood pressures, body mass index (BMI) and wait-hip circumference ratio (WHR) will be measured (light clothing and no shoes).
    3. Blood tests: 10ml of fasting blood will be taken for WBC platelet, fasting glucose, HgbA1C, low density lipoprotein cholesterol, hsC-reactive protein, fibrinogen and IL-6.
  • Vascular Studies:

Endothelial function, flow-mediated dilation (FMD) of the brachial artery and carotid IMT will be studied by using high resolution ultrasound.

(i) Endothelial function, (brachial flow-mediated dilation, FMD) will be studied by using high resolution ultrasound, as described previously. [12,22-24] In brief, the diameter of the brachial artery will be measured on B-mode ultrasound images, using a linear array transducer (HF L38) with a median frequency of 13-6MHz and a standard Sonosite (MicroMaxx) system. Forearm tourniquet cuff placement will be applied to induce reactive hyperemia on deflation. Scans of brachial artery 10cm proximal to elbow will be acquired at rest, during reactive hyperemia (to induce flow-mediated endothelium-dependent dilation, FMD). FMD will be expressed as % of dilation from baseline vessel diameter normalized with vessel strain. Hyperemia is calculated as the % increase in blood flow after cuff deflation compared with baseline.

(ii) Carotid intima-media thickness (CIMT) measurement - B-mode ultrasound examinations will be performed using a 10-5 probe, with a 7.5 MHz scanning frequency linear array transducer. All carotid scans will be performed by a single operator after a predetermined, standardized scanning protocol for the right and left carotid arteries as described by Salonen and Salonen [16] and Touboul et al [19], using images of the far wall of the distal 10 mm of the common carotid arteries. All scans will be recorded on super-VHS videotape for subsequent off-line analysis for intima-media thickness (IMT), using a verified automatic edge-detecting and measurement software package as described previously. [19-24] The intra-observer variability of mean IMT is 0.003 to 0.011mm (CV 0.998%).

3.3 Outcomes

3.3.1 Primary outcomes: Vascular Parameters: Brachial FMD (%) and Carotid IMT (mm) at baseline, 24 weeks and 1 year.

3.3.2 Secondary outcomes: (i) Carotid femoral pulse wave velocity, cfPWV (mm/sec) at baseline and 24 weeks.

(ii) Other important traditional atherosclerosis risk factors: BMI (weight kg/ height m^2), glucose (mmol/l), lipid profiles (mmol/l), HgbA1-C (%), creatinine (umol/L), haemoglobin (g/dl), hsCRP (mg/l), Fibrinogen (mg/dl) and IL-6 (pg/ml) at baseline, 24 weeks and 1 year.

3.3.3 Safety profiles (if any) including CVS event and hospitalization at 1 year,

4. Compliance with Declaration of Helsinki. The design, methodology and conduction of project are in compliance with Declaration of Helsinki.

5. Data processing and analysis:

(5.1) Power Calculation: The Proc Power in the STS 9.2 statistical packages (SAS Institute Inc. Cary. NC, US) was used to calculate the sample size for FMD and carotid IMT. Data from our previous studies on Chinese adults in Hong Kong reported FMD was in 6-8% +/- 1.3%, and carotid IMT was 0.55-0.68mm +/- 0.1mm. On the assumption of post IRE brachial FMD will improve to 6.7-8.7 +/- 1.4%, and carotid IMT will reduce to 0.51-0.61mm +/- 0.11mm, recruitment of 200 Chinese adults (100 in each group) will be adequately powered (85%) to detect a group difference in brachial FMD of 1.2% and in carotid IMT of 0.06mm (12%), at 1 year between the two treatment groups.

(5.2). Data Analysis: Statistical Analysis System SPSS version 28 (SAS Institute Inc., Cary, NC, US) will be used for all statistical analyses. Descriptive methods will be used to describe characteristics of cardiovascular risks. The primary endpoints are AMBP, brachial FMD and carotid IMT; serological inflammatory biomarkers (Neutrophil/ monocyte ratio and Platelet), hsCRP, fibrinogen and IL-6 are secondary endpoints. Students' T-tests will be used to detect the group differences in brachial FMD and carotid IMT. Multivariable linear and logistic regressions will be used to calculate the risk magnitude by IRE vs usual care and stretching exercise interventions, and to control potential confounders such as traditional cardiovascular risk factors.

Studietype

Ingrijpend

Inschrijving (Geschat)

200

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

      • Shatin, Hongkong
        • Werving
        • The Chinese University of Hong Kong, Department of Medicine & Therapeutics
        • Contact:
        • Contact:

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Ja

Beschrijving

Inclusion Criteria:

  1. asymptomatic clinically stable adults
  2. aged >18 years
  3. Both genders
  4. Suboptimal BP (on stable medication) with SBP 135-160mmHG on ambulatory BP monitoring (AMBP)
  5. Agreeable to no drug changes in coming 1 year 24 weeks
  6. Agreeable to provide informed written consent form
  7. Agreeable to have AMBP and ultrasonic (FMD & IMT) scan third (baseline, 24 weeks and preferably 1 year)

Exclusion Criteria:

  1. relative contraindications to AMBP (e.g. atrial fibrillation)
  2. severe osteoarthritis of knee
  3. known secondary HT
  4. pregnancy/breastfeeding
  5. active malignancy
  6. Serious coronary profiles, (unstable angina), renal or hepatic derangement
  7. Need to change medications for control BP at 24 weeks ( SBP>160 mmHg)

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Preventie
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Dubbele

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Anti HT + Isometric Resistance Squatting Exercise (100 Adults)
A more linear thigh-leg squatting angle is allowed in initial 2 weeks, but aiming at 90 degree thigh-leg angle after 4 weeks.
14 minutes per session (2 mins x 4 sets, 2 mins rest in between, 3 session per week)
Actieve vergelijker: Anti HT + Stretching Exercise (100 Adults)
A liberal leg stretching excerise will be practised
2 mins x 4 sets, 2 mins rest in between, 3 sessions per week

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline, 24 weeks and 1 year
Changes in Brachial FMD (%)
Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline, 24 weeks and 1 year
Changes in Carotid IMT (mm)
Baseline, 24 weeks and 1 year

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline and 24 weeks
Changes in Carotid femoral pulse wave velocity, cfPWV (mm/sec)
Baseline and 24 weeks
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline, 24 weeks and 1 year

Other important traditional atherosclerosis risk factors:

Changes in BMI (weight kg/ height m^2)

Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline, 24 weeks and 1 year
Changes in Fasting Glucose (mmol/l)
Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline, 24 weeks and 1 year

Changes in Fasting Lipid profiles (mmol/l)

  1. Changes in high density lipoprotein cholesterol (HDL-C) (mmol/l)
  2. Changes in low density lipoprotein cholesterol (LDL-C) (mmol/l)
  3. Changes in Triglyceride (TG) (mmol/l)
Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline, 24 weeks and 1 year
HgbA1-C (%)
Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline, 24 weeks and 1 year
Creatinine (umol/L)
Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline, 24 weeks and 1 year
Haemoglobin (g/dl)
Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline, 24 weeks and 1 year
hsCRP (mg/l)
Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline, 24 weeks and 1 year
Fibrinogen (mg/dl)
Baseline, 24 weeks and 1 year
The Impact of Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension
Tijdsspanne: Baseline, 24 weeks and 1 year
IL-6 (pg/ml)
Baseline, 24 weeks and 1 year

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Kam Sang Woo, Chinese University of Hong Kong

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

16 april 2025

Primaire voltooiing (Geschat)

30 juli 2027

Studie voltooiing (Geschat)

30 december 2027

Studieregistratiedata

Eerst ingediend

17 september 2025

Eerst ingediend dat voldeed aan de QC-criteria

23 juni 2026

Eerst geplaatst (Werkelijk)

24 juni 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

11 september 2026

Laatste update ingediend die voldeed aan QC-criteria

9 september 2026

Laatst geverifieerd

1 juni 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

There is a plan to make IPD and related data dictionaries available. All IPD that underline results in a publication.

IPD-tijdsbestek voor delen

These materials will be available and shared on reasonable requests to Prof KS Woo from January 2025 till 30 December 2027

IPD-toegangscriteria voor delen

These materials will be available and shared on reasonable requests to Prof KS Woo from January 2025 till 30 December 2027 (kamsangwoo@cuhk.edu.hk/ crec@cuhk.edu.hk)

IPD delen Ondersteunend informatietype

  • LEERPROTOCOOL
  • SAP
  • ICF

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren